Product Images Pyrukynd

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Pyrukynd NDC 71334-230 by Agios Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - pyrukynd 01

Chemical Structure - pyrukynd 01

Figure 1 - pyrukynd 02

Figure 1 - pyrukynd 02

Figure 2 - pyrukynd 03

Figure 2 - pyrukynd 03

Principal Display Panel - 5 mg Tablet Blister Pack Carton - pyrukynd 04

Principal Display Panel - 5 mg Tablet Blister Pack Carton - pyrukynd 04

This is a description of the storage and usage instructions for Pyrkind tablets by Agios Pharmaceuticals. It includes information on how to store the tablets and their recommended usage as well as instructions to keep the tablets out of reach of children. The text also contains a warning to not split, crush, chew or dissolve the tablets before swallowing. It provides contact information for further inquiries and information on the quantity contained in the product.*

Principal Display Panel - 20 mg Tablet Blister Pack Carton - pyrukynd 05

Principal Display Panel - 20 mg Tablet Blister Pack Carton - pyrukynd 05

This is a medication description for Pyrukind tablets, which contain 20mg mitapivat, a medicine used for treating certain blood disorders. The recommended dosage information is not available and the tablets should be kept away from children and stored in a controlled room temperature. The manufacturer of the tablets is Agios Pharmaceuticals Inc. and for any further information, one can visit their website or call the given number. The tablets are available in a four-week supply pack and caution must be taken not to use them if the seal is broken or damaged.*

Principal Display Panel - 50 mg Tablet Blister Pack Carton - pyrukynd 06

Principal Display Panel - 50 mg Tablet Blister Pack Carton - pyrukynd 06

Principal Display Panel - 5 mg Tablet Blister Pack Carton - 220-11 - pyrukynd 07

Principal Display Panel - 5 mg Tablet Blister Pack Carton - 220-11 - pyrukynd 07

This is a medication label for Pyruvate Kinase Deficiency in adults that contains information about the dosage and directions for use. The tablet should be swallowed whole and not crushed or dissolved. It is recommended to store the medication at room temperature. The drug name is Pyrukynd and the strength is 5mg.*

Principal Display Panel - 20 mg/5 mg Tablet Blister Pack Carton - 225-12 - pyrukynd 08

Principal Display Panel - 20 mg/5 mg Tablet Blister Pack Carton - 225-12 - pyrukynd 08

This is a label for a medication called Pyruvate Kinase Deficiency Mitapivat Tablets which come in a Taper Pack of 20mg and 5mg. The label includes warnings not to use broken or damaged tablets, and not to split, crush, chew or dissolve the tablets. It also includes storage instructions and contact information for medical recommendations.*

Principal Display Panel - 50 mg/20 mg Tablet Blister Pack Carton - 230-13 - pyrukynd 09

Principal Display Panel - 50 mg/20 mg Tablet Blister Pack Carton - 230-13 - pyrukynd 09

This appears to be a medication label for tablets called "pyrukynd" with dosages of 50mg and 20mg. The label includes information on how to take the medication, caution against breaking or damaging the tablets, and recommended storage conditions. It also advises against crushing, chewing, or dissolving the tablets. However, the label contains several errors and incomplete sentences, making it difficult to understand the complete instructions.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.